BRCA MUTATIONS LEAD TO XIAP OVEREXPRESSION AND SENSITISE OVARIAN CANCER TO INHIBITOR OF APOPTOSIS (IAP) FAMILY INHIBITORS Article Cremona Mattia, Vandenberg C.J., Farrelly A.M., Madden S.F., Morgan Clare, Kalachand Roshni, McAlpine J.N., Toomey Sinead, Huntsman D.G., Grogan Liam, Breathnach Oscar, Morris Patrick, Carey M.S., Scott C.L., Hennessy B.T. British Journal of Cancer. Nature Publishing Group. Vol. 127. 2022. P. 488-499
RESTORATION OF PLAKOGLOBIN EXPRESSION IN BLADDER CARCINOMA CELL LINES SUPPRESSES CELL MIGRATION AND TUMORIGENIC POTENTIAL Article Rieger-Christ K.M., Ng L, Hanley R.S., Durrani O, Ma H, Yee A.S., Libertino J.A., Summerhayes I.C. British Journal of Cancer. Nature Publishing Group. Vol. 92. 2005. P. 2153-2159
RANDOMIZED PHASE II TRIAL ASSESSING ESTRAMUSTINE AND VINBLASTINE COMBINATION CHEMOTHERAPY VS ESTRAMUSTINE ALONE IN PATIENTS WITH PROGRESSIVE HORMONE-ESCAPED METASTATIC PROSTATE CANCER Article Albrecht W, Van Poppel H, Horenblas S, Mickisch G, Horwich A, Serretta V, Casetta G, Maréchal J.M., Jones W.G., Kalman S, Sylvester R British Journal of Cancer. Nature Publishing Group. Vol. 90. 2004. P. 100-105
FUNCTIONAL EVALUATION OF THE APOPTOSOME IN RENAL CELL CARCINOMA Article Gerhard M.C., Zantl N, Weirich G, Schliep S, Seiffert B, Häcker G British Journal of Cancer. Nature Publishing Group. Vol. 89. 2003. P. 2147-2154
MONOCYTE CHEMOATTRACTANT PROTEIN-1 SERUM LEVELS IN OVARIAN CANCER PATIENTS Article Hefler L, Tempfer C, Heinze G, Mayerhofer K, Breitenecker G, Leodolter S, Reinthaller A, Kainz C British Journal of Cancer. Nature Publishing Group. Vol. 81. 1999. P. 855-859
ПОЛИТИЧЕСКИЕ ВЫЗОВЫ И ПОЛИТИЧЕСКИЙ ДИАЛОГ В УСЛОВИЯХ ГЛОБАЛЬНОЙ ТУРБУЛЕНТНОСТИ Conference proceedings Всероссийская конференция РАПН с международным участием "Политические вызовы и политический диалог в условиях глобальной турбулентности". 2022.
САНКТ-ПЕТЕРБУРГСКИЕ ДЕРМАТОЛОГИЧЕСКИЕ ЧТЕНИЯ Conference proceedings Санкт-Петербургские дерматологические чтения. Санкт-Петербургская общественная организация «Человек и его здоровье». 2022.